Hims & Hers Health is upgraded to a speculative Buy after a 20% drop, with growth potential in GLP-1 sales outweighing key ...

Technological innovation and personalized care are transforming Hims & Hers into a proactive health platform. Read why I ...

The renowned health and wellness platform, Hims & Hers Health, Inc. HIMS, has strategically prioritized the integration of technology platforms to scale personalized healthcare delivery. A critical ...

Great things are happening to the stocks in this article. They’re all outperforming the market over the last month because of ...

Progressive activists in Hassan demand timely opening of super speciality hospital for improved health services.

Popular digital weight loss app, Noom (NOOM) undercuts Novo Nordisk's Wegovy by offering quarter-dose packs at $119 for the ...

The telehealth and wellness stock tanked more than 12% Aug. 5, a day after posting mixed Q2 earnings. More importantly, Bank ...

Novo Nordisk’s head of U.S. marketing, Ulrich Otte, is no longer in the role and is exploring other internal opportunities at the company outside of the U.S.

Novo Nordisk CFO Karsten Munk Knudsen tells Yahoo Finance the company understands the pressure it is under to deliver better ...

The Microdose GLP-1Rx Program will offer low-dose GLP-1 prescriptions combined with behavioral coaching, clinical monitoring and medication management.

Maybe you stock up on ice cream after a difficult day at work or reach for chocolate after a disagreement with your partner.

Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...